abstract |
The present invention relates to a bifunctional fusion protein containing an extracellular domain of CTLA4 and an anti-IL-17 antibody, a gene encoding the protein, a vector containing the gene, a host cell containing the vector, and the protein A pharmaceutical composition is provided. |